$-0.01 EPS Expected for Pharma Bio Serv Inc (PBSV)

August 30, 2017 – By Adrian Mccoy

Analysts await Pharma Bio Serv Inc (OTCMKTS:PBSV) to report earnings on September, 13. They expect $-0.01 earnings per share, 0.00 % or $0.00 from last year’s $-0.01 per share. After $-0.01 actual earnings per share reported by Pharma Bio Serv Inc for the previous quarter, Wall Street now forecasts 0.00 % EPS growth. It closed at $0.6 lastly. It is down 0.00% since August 30, 2016 and is . It has underperformed by 16.70% the S&P500.

Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The company has market cap of $13.86 million. The Firm operates through four divisions: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division . It currently has negative earnings. The Firm provides a range of compliance-related consulting services.

More news for Pharma Bio Serv Inc (OTCMKTS:PBSV) were recently published by: Marketwired.com, which released: “Pharma-Bio Serv Signs Strategic Collaboration Agreement With Quality Technical …” on October 09, 2014. Seekingalpha.com‘s article titled: “What Is Pharma-Bio Serv’s Goal With An M&A Advisor?” and published on November 20, 2015 is yet another important article.